On March 5, 2024, the U.S. Food and Drug Administration (FDA) issued an industry guidance titlferrous fumarate and folic acid tablet uses in kannadaed Dietarferrous bisglycinate constipationy Supplements: New Dietferric gluconate ironary Ingredient Notification Procedures and Timeframes: Guidance for Industry1(hereafter Guidance). This Guidance is intended to help manufacturers and diron as ferrous bisglycinateistributors of new dietary ingredients (NDIs) and dietary supplements prepare and submit new dietary ingredient notferrous fumarateifications (NDINs) to the FDA.